| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5138698 | Journal of Proteomics | 2017 | 52 Pages |
Abstract
Inhibition of metalloproteases as a therapeutic approach has failed because there is limited knowledge of the degradome of individual proteases as well as the cellular function of cleaved substrates. Using different proteomic techniques, this study uncovered novel substrates that can be modulated by ADAM17 in oral squamous cell carcinoma cell line. Glypican-1 was validated as a novel substrate for ADAM17, with important function in adhesion, proliferation and migration of carcinoma cells. Therefore, this study opens new avenues regarding the proteolysis-mediated function of GPC1 by ADAM17.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
Rebeca Kawahara, Daniela Campos Granato, Sami Yokoo, Romênia Ramos Domingues, Daniel Maragno Trindade, Adriana Franco Paes Leme,